Screener
Oruka Therapeutics, Inc. ORKA Deferred Tax Assets and Other Non-Current Assets
Deferred Tax Assets and Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Oruka Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The source filing: Oruka Therapeutics, Inc.’s 10-Q, filed May 13, 2026.
- Filed
- May 13, 2026, 4:01 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001213900-26-055769
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Marketable securities, long-term | 107,123 | 142,539 |
| Property and equipment, net | 318 | 288 |
| Operating lease right-of-use assets | 1,687 | 1,830 |
| Other non-current assets | 103 | 103 |
| Total assets | $504,480 | $488,617 |
| Liabilities and Stockholders’ Equity | ||
| Current liabilities: | ||
| Accounts payable | $3,662 | $4,155 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Oruka Therapeutics, Inc.'s deferred tax assets and other non-current assets?
- Oruka Therapeutics, Inc. (ORKA) reported deferred tax assets and other non-current assets of $103K in Q1 2026.
- How has Oruka Therapeutics, Inc.'s deferred tax assets and other non-current assets changed year-over-year?
- Oruka Therapeutics, Inc.'s deferred tax assets and other non-current assets decreased by 0.0% year-over-year, from $103K to $103K.
- What is the long-term trend for Oruka Therapeutics, Inc.'s deferred tax assets and other non-current assets?
- Over 5 years (2020 to 2025), Oruka Therapeutics, Inc.'s deferred tax assets and other non-current assets has grown at a 53.7% compound annual growth rate (CAGR), from $12K to $103K.
Ask your AI about Oruka Therapeutics, Inc.'s deferred tax assets and other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude